Infections of long intravenous lines: new developments and controversies.
Samore
M H
MH
Department of Medicine, University of Utah School of Medicine, Salt Lake City, USA.
Burke
J P
JP
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002176:Candida albicans / Q000302:isolation & purification; D002405:Catheterization, Central Venous / Q000009:adverse effects* / Q000295:instrumentation; D002406:Catheterization, Peripheral / Q000009:adverse effects* / Q000295:instrumentation; D003428:Cross Infection / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D006801:Humans; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D013211:Staphylococcus aureus / Q000302:isolation & purification; D009626:Terminology as Topic; D014656:Vascular Surgical Procedures
D000900:Anti-Bacterial Agents